Reuters logo
4 months ago
BRIEF-Philips receives FDA clearance to market pathology solution in the U.S.
April 13, 2017 / 12:16 PM / 4 months ago

BRIEF-Philips receives FDA clearance to market pathology solution in the U.S.

April 13 (Reuters) - Koninklijke Philips NV:

* Receives clearance from the U.S. Food and Drug Administration (FDA) to market Philips Intellisite pathology solution for primary diagnostic use in the U.S. Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below